# OnCo record idea-acc-pharmacist-interaction-review-oral-anticancer (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-acc-pharmacist-interaction-review-oral-anticancer/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-acc-pharmacist-interaction-review-oral-anticancer" ;
  schema:name "Pharmacist interaction check before every oral cancer-drug prescription"@en ;
  schema:description "Oral kinase inhibitors, CDK4/6 inhibitors and hormonal agents interact with proton pump inhibitors, anticoagulants, statins and antiarrhythmics, and are increasingly prescribed to older patients taking all of them. A mandatory oncology pharmacist review at initiation, dose change and refill, with a structured monitoring plan, would catch these interactions systematically."@en ;
  schema:url <https://onco.cc/ideas/idea-acc-pharmacist-interaction-review-oral-anticancer/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(21)01789-X> ;
  onco:related <https://onco.cc/ideas/idea-acc-structured-deprescribing-at-diagnosis/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/osimertinib/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-aging-comorbidity/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .